高血糖而无糖尿病和新发糖尿病均与 COVID-19 的预后不良相关。
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
机构信息
Department of Diabetes & Endocrinology, G.D Hospital & Diabetes Institute, Kolkata, India.
Department of Diabetes & Endocrinology, G.D Hospital & Diabetes Institute, Kolkata, India.
出版信息
Diabetes Res Clin Pract. 2020 Sep;167:108382. doi: 10.1016/j.diabres.2020.108382. Epub 2020 Aug 25.
Abstract
Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not uncommonly encountered in patients with COVID-19. Increasingly, all evidence currently available hints that both new-onset hyperglycemia without diabetes and new-onset diabetes in COVID-19 is associated with a poorer outcome compared with normoglycemic individuals and people with pre-existing diabetes.
摘要
在 COVID-19 患者中，经常会发现血糖升高或未升高的糖尿病患者，这是一种新出现的现象。越来越多的现有证据表明，与血糖正常者和患有糖尿病的患者相比，COVID-19 患者中出现的新发无糖尿病性高血糖和新发糖尿病与更差的预后相关。
相似文献
1
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
Diabetes Res Clin Pract. 2020 Sep;167:108382. doi: 10.1016/j.diabres.2020.108382. Epub 2020 Aug 25.
2
Hyperglycemia is a strong predictor of poor prognosis in COVID-19.
Diabetes Res Clin Pract. 2020 Sep;167:108338. doi: 10.1016/j.diabres.2020.108338. Epub 2020 Jul 24.
3
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
4
Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
Front Endocrinol (Lausanne). 2020 Jul 10;11:525. doi: 10.3389/fendo.2020.00525. eCollection 2020.
5
Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):725-727. doi: 10.1016/j.dsx.2020.05.037. Epub 2020 May 27.
6
The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.
Diabetes Metab J. 2020 Aug;44(4):602-613. doi: 10.4093/dmj.2020.0146. Epub 2020 Aug 12.
7
[Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].
Salud Publica Mex. 2020 Sep-Oct;62(5):456-457. doi: 10.21149/11546.
8
[The endocrine and metabolic link between COVID-19, diabetes and obesity].
Ugeskr Laeger. 2020 Jul 13;182(29).
9
Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.
BMJ Open Diabetes Res Care. 2020 Jun;8(1). doi: 10.1136/bmjdrc-2020-001476.
10
Commentary: COVID-19 in patients with diabetes.
Metabolism. 2020 Jun;107:154217. doi: 10.1016/j.metabol.2020.154217. Epub 2020 Mar 24.
引用本文的文献
1
Hyperglycemia, diabetes, and de novo diabetes in patients hospitalized in intensive care units for COVID-19 in Colombia: Results from a longitudinal cohort study.
J Crit Care Med (Targu Mures). 2025 Jul 31;11(3):257-264. doi: 10.2478/jccm-2025-0026. eCollection 2025 Jul.
2
Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates.
PLoS Pathog. 2025 Jul 24;21(7):e1012988. doi: 10.1371/journal.ppat.1012988. eCollection 2025 Jul.
3
The Impact of SARS-CoV-2 Infection on Glucose Homeostasis in Hospitalized Patients with Pulmonary Impairment.
Diagnostics (Basel). 2025 Feb 25;15(5):554. doi: 10.3390/diagnostics15050554.
4
Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates.
bioRxiv. 2025 Feb 22:2025.02.18.638792. doi: 10.1101/2025.02.18.638792.
5
Clinical features of and severity risk factors for COVID-19 in adults during the predominance of SARS-CoV-2 XBB variants in Okinawa, Japan.
PLoS One. 2024 Oct 31;19(10):e0309808. doi: 10.1371/journal.pone.0309808. eCollection 2024.
6
Insulin Resistance in Long COVID-19 Syndrome.
J Pers Med. 2024 Aug 28;14(9):911. doi: 10.3390/jpm14090911.
7
Prevalence and short-term clinical impacts of new-onset diabetes mellitus among patients with COVID-19 in jazan region, Saudi Arabia.
BMC Endocr Disord. 2024 Sep 20;24(1):197. doi: 10.1186/s12902-024-01724-z.
8
Effect of fasting plasma glucose level in severe fever and thrombocytopenia syndrome patients without diabetes.
PLoS Negl Trop Dis. 2024 Apr 16;18(4):e0012125. doi: 10.1371/journal.pntd.0012125. eCollection 2024 Apr.
9
Long-Term Persistence of COVID-Induced Hyperglycemia: A Cohort Study.
Am J Trop Med Hyg. 2024 Feb 13;110(3):512-517. doi: 10.4269/ajtmh.22-0695. Print 2024 Mar 6.
10
Assessment of the Negative Factors for the Clinical Outcome in Patients with SARS-CoV-2 Infection and Type 2 Diabetes Mellitus.
Diabetes Metab Syndr Obes. 2024 Jan 22;17:271-282. doi: 10.2147/DMSO.S447835. eCollection 2024.
本文引用的文献
1
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
2
Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.
Diabetes Care. 2020 Oct;43(10):2345-2348. doi: 10.2337/dc20-1380. Epub 2020 Aug 11.
3
COVID-19 in people with diabetes: understanding the reasons for worse outcomes.
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792. doi: 10.1016/S2213-8587(20)30238-2. Epub 2020 Jul 17.
4
Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.
Diabetologia. 2020 Oct;63(10):2102-2111. doi: 10.1007/s00125-020-05209-1. Epub 2020 Jul 10.
5
Hyperglycaemia on admission to hospital and COVID-19.
Diabetologia. 2020 Nov;63(11):2486-2487. doi: 10.1007/s00125-020-05216-2. Epub 2020 Jul 6.
6
New-Onset Diabetes in Covid-19.
N Engl J Med. 2020 Aug 20;383(8):789-790. doi: 10.1056/NEJMc2018688. Epub 2020 Jun 12.
7
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.
Diabetes Obes Metab. 2020 Oct;22(10):1897-1906. doi: 10.1111/dom.14099. Epub 2020 Jun 30.
8
Why is hyperglycaemia worsening COVID-19 and its prognosis?
Diabetes Obes Metab. 2020 Oct;22(10):1951-1952. doi: 10.1111/dom.14098. Epub 2020 Jun 21.
9
COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes.
Diabetes Metab. 2021 Feb;47(1):101162. doi: 10.1016/j.diabet.2020.05.004. Epub 2020 May 21.
10
The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan.
Diabetes Obes Metab. 2020 Aug;22(8):1443-1454. doi: 10.1111/dom.14086. Epub 2020 Jun 17.
Zotero 插件